{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:28:07Z","timestamp":1786994887557,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR14711\/NNT\/28\/911\/2015"],"award-info":[{"award-number":["BT\/PR14711\/NNT\/28\/911\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR27008\/NNT\/28\/1525\/-2017"],"award-info":[{"award-number":["BT\/PR27008\/NNT\/28\/1525\/-2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ECR\/2016\/000633\/LS"],"award-info":[{"award-number":["ECR\/2016\/000633\/LS"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["YSS\/2015\/001706"],"award-info":[{"award-number":["YSS\/2015\/001706"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.neuropharm.2020.108372","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T23:19:08Z","timestamp":1604445548000},"page":"108372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of \u03b1-synuclein in experimental Parkinson's disease models"],"prefix":"10.1016","volume":"194","author":[{"given":"Anup K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasree Roy","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108372_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031870","article-title":"Bmi1 is down-regulated in the aging brain and displays antioxidant and protective activities in neurons","volume":"7","author":"Abdouh","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108372_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008104","article-title":"The E3 ubiquitin-ligase bmi1\/Ring1A controls the proteasomal degradation of Top2\u03b1 cleavage complex \u2013 a potentially new drug target","volume":"4","author":"Alchanati","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108372_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/jnr.24220","article-title":"The neuroprotective role of melatonin in neurological disorders","volume":"96","author":"Alghamdi","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40478-017-0452-6","article-title":"Mechanisms underlying extensive Ser129-phosphorylation in alpha-synuclein aggregates","volume":"5","author":"Arawaka","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neuropharm.2020.108372_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/00001756-200203250-00023","article-title":"Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells","volume":"13","author":"Armstrong","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2020.108372_bib8","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/nar\/gkv1223","article-title":"RING1A and BMI1 bookmark active genes via ubiquitination of chromatin-associated proteins","volume":"44","author":"Arora","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-017-0617-8","article-title":"BMI1, a new target of CK2\u03b1","volume":"16","author":"Banerjee Mustafi","year":"2017","journal-title":"Mol. Canc."},{"key":"10.1016\/j.neuropharm.2020.108372_bib10","first-page":"1571","article-title":"Loss of Bmi1 causes anomalies in retinal development and degeneration of cone photoreceptors","volume":"143","author":"Barabino","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2020.108372_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108372_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JPD-160921","article-title":"The proteasome inhibition model of Parkinson's disease","volume":"7","author":"Bentea","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuropharm.2020.108372_bib13","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1523\/JNEUROSCI.1788-16.2017","article-title":"Prying into the prion hypothesis for Parkinson's disease","volume":"37","author":"Brundin","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fnins.2019.00382","article-title":"Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson disease","volume":"13","author":"Canerina-Amaro","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.108372_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","article-title":"Role of bmi-1 and Ring1A in H2A ubiquitylation and hox gene silencing","volume":"20","author":"Cao","year":"2005","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2020.108372_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-079X.2011.00945.x","article-title":"Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and alpha-synuclein aggregation","volume":"52","author":"Chang","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1523\/JNEUROSCI.5303-08.2009","article-title":"The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity","volume":"29","author":"Chatoo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mce.2015.10.012","article-title":"Effects of melatonin and its analogues on neural stem cells","volume":"420","author":"Chu","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jpi.12343","article-title":"Melatonin prevents the dynamin-related protein 1-dependent mitochondrial fission and oxidative insult in the cortical neurons after 1-methyl-4-phenylpyridinium treatment","volume":"61","author":"Chuang","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12515","article-title":"Melatonin induces mechanisms of brain resilience against neurodegeneration","volume":"65","author":"Corpas","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2669","article-title":"Transcriptional regulation by Polycomb group proteins","volume":"20","author":"Di Croce","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/pro.3412","article-title":"Exploring the role of post-translational modifications in regulating alpha-synuclein interactions by studying the effects of phosphorylation on nanobody binding","volume":"27","author":"El Turk","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","article-title":"Emerging therapies in Parkinson disease \u2014 repurposed drugs and new approaches","volume":"15","author":"Elkouzi","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib25","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.celrep.2018.04.097","article-title":"Modeling late-onset sporadic alzheimer's disease through BMI1 deficiency","volume":"23","author":"Flamier","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2020.108372_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/omi.2012.0105","article-title":"Gene silencing and Polycomb group proteins: an overview of their structure, mechanisms and phylogenetics","volume":"17","author":"Golbabapour","year":"2013","journal-title":"OMICS A J. Integr. Biol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/j.1601-183X.2009.00552.x","article-title":"Allen reference atlas. A digital color brain atlas of the C57BL\/6J male mouse - by H. W. Dong","volume":"9","author":"Goldowitz","year":"2010","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2020.108372_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-079X.2006.00390.x","article-title":"Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells","volume":"42","author":"Ishido","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1034\/j.1600-079X.2000.290206.x","article-title":"Comparative effects of melatonin, l-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro","volume":"29","author":"Khaldy","year":"2000","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neulet.2008.03.053","article-title":"Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells","volume":"436","author":"Klongpanichapak","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108372_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10456-017-9565-6","article-title":"Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment","volume":"20","author":"Lagerweij","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.neuropharm.2020.108372_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","article-title":"The epigenetics of aging and neurodegeneration","volume":"131","author":"Lardenoije","year":"2015","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2020.108372_bib33","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/nn.3564","article-title":"EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia","volume":"16","author":"Li","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib34","doi-asserted-by":"crossref","first-page":"20643","DOI":"10.1074\/jbc.M602461200","article-title":"Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2020.108372_bib35","article-title":"Role of the ubiquitin proteasome system in Parkinson's disease","volume":"8","author":"Lim","year":"2007","journal-title":"BMC Biochem."},{"key":"10.1016\/j.neuropharm.2020.108372_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-079X.2007.00456.x","article-title":"Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein","volume":"43","author":"Lin","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib37","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","article-title":"Conditional expression of Parkinson's disease-related mutant \u03b1-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1","volume":"32","author":"Lin","year":"2012","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108372_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003199","article-title":"Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus","volume":"5","author":"Liu","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2020.108372_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","article-title":"Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms","volume":"32","author":"Margueron","year":"2008","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2020.108372_bib40","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00018-019-03008-5","article-title":"Mitochondrial stress triggers a pro-survival response through epigenetic modifications of nuclear DNA","volume":"76","author":"Mayorga","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nature02060","article-title":"Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation","volume":"425","author":"Molofsky","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108372_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200369","article-title":"Validation of quantitative real-time PCR reference genes for the determination of seasonal and labor-specific gene expression profiles in the head of Western honey bee, Apis mellifera","volume":"13","author":"Moon","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108372_bib43","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1172\/JCI57477","article-title":"Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer","volume":"122","author":"Nacerddine","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2020.108372_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108372_bib45","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.neurobiolaging.2011.10.015","article-title":"Effect of melatonin on \u03b1-synuclein self-assembly and cytotoxicity","volume":"33","author":"Ono","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2020.108372_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JPD-160779","article-title":"Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuropharm.2020.108372_bib47","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","article-title":"Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells","volume":"62","author":"Perfeito","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nantod.2010.03.003","article-title":"Targeted nanodelivery of drugs and diagnostics","volume":"5","author":"Phillips","year":"2010","journal-title":"Nano Today"},{"key":"10.1016\/j.neuropharm.2020.108372_bib50","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108372_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/ol.2013.1413","article-title":"Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro","volume":"6","author":"Qu","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.neuropharm.2020.108372_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10409230903044914","article-title":"Reducing oxidative\/nitrosative stress: a newly-discovered genre for melatonin","volume":"44","author":"Reiter","year":"2009","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib53","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/18715273113126660195","article-title":"\u03b1-Synuclein ubiquitination and novel therapeutic targets for Parkinson's disease","volume":"13","author":"Rott","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2020.108372_bib54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-079X.2011.00927.x","article-title":"Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats","volume":"52","author":"Sae-Ung","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib55","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1074\/jbc.M115.705095","article-title":"Effects of serine 129 phosphorylation on alpha-synuclein aggregation, membrane association, and internalization","volume":"291","author":"Samuel","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108372_bib56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jnr.10777","article-title":"An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells","volume":"74","author":"Shamoto-Nagai","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/0008-5472.CAN-17-1805","article-title":"The E3 ligase ring1 targets p53 for degradation and promotes cancer cell proliferation and survival","volume":"78","author":"Shen","year":"2018","journal-title":"Canc. Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib58","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib60","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1039\/C9BM01602C","article-title":"Melatonin\/polydopamine nanostructures for collective neuroprotection based Parkinson\u2019s disease therapy","volume":"8","author":"Srivastava","year":"2020","journal-title":"Biomater Sci"},{"key":"10.1016\/j.neuropharm.2020.108372_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000502","article-title":"Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance","volume":"3","author":"Stapels","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2020.108372_bib63","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","article-title":"Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death","volume":"283","author":"Sugeno","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108372_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02143-18","article-title":"A noncanonical function of polycomb repressive complexes promotes human cytomegalovirus lytic DNA replication and serves as a novel cellular target for antiviral intervention","volume":"93","author":"Svrlanska","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib65","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/cne.23901","article-title":"Brain region-dependent differential expression of alpha-synuclein","volume":"524","author":"Taguchi","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib66","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease","volume":"2","author":"Thomas","year":"2007","journal-title":"Hum Mol Genet 16 Spec No."},{"key":"10.1016\/j.neuropharm.2020.108372_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00277","article-title":"Entanglement of genetics and epigenetics in Parkinson's disease","volume":"13","author":"van Heesbeen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00008","article-title":"Hemoglobin mRNA changes in the frontal cortex of patients with neurodegenerative diseases","volume":"12","author":"Vanni","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biocel.2016.03.007","article-title":"The novel mechanism of rotenone-induced alpha-synuclein phosphorylation via reduced protein phosphatase 2A activity","volume":"75","author":"Wang","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2020.108372_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2017.02.041","article-title":"EZH2 regulates spinal neuroinflammation in rats with neuropathic pain","volume":"349","author":"Yadav","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108372_bib71","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1523\/JNEUROSCI.4129-13.2014","article-title":"Ezh2 regulates adult hippocampal neurogenesis and memory","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108372_bib72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbr.2013.07.051","article-title":"Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII","volume":"256","author":"Zhang","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108372_bib73","doi-asserted-by":"crossref","first-page":"9968","DOI":"10.1038\/s41598-017-07442-y","article-title":"Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:10:35Z","timestamp":1778627435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820304408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":70,"alternative-id":["S0028390820304408"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108372","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of \u03b1-synuclein in experimental Parkinson's disease models","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108372"}}